{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 10:29:26", "close_timestamp": 1637404166432, "created": "20/11/2021 10:29:25", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "cd783969-0843-42e7-8b11-d45e88954d2f", "open_date_time": "2021-10-20 10:23:57", "open_timestamp": 1637403837251, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "This is a study that shows that invermectin might be able to kill covid. There is limited testing and results are dependent", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 329181, "what": "invermectin use as a COVID treatment ", "when_happened": "current_month", "where_location": "Monash University", "who": "Dr Kylie Wagstaff, invermectin", "why": "study shows one possible covid treament "}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 10:41:19", "close_timestamp": 1637404879990, "created": "20/11/2021 10:41:21", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "b1a15b1c-340e-47bf-ad3c-cde9121df522", "open_date_time": "2021-10-20 10:35:19", "open_timestamp": 1637404519576, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "It is a about a Covid vaccine that was developed in the US and is effective but that will probably not be used in the United States and will instead be used in other countries. It is unclear how effective it is against the Delta varient. ", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 360414, "what": "new covid vaccine", "when_happened": "current_month", "where_location": "united states", "who": "Novavax, Nancy Jaser, United States", "why": "it talks about a new covid vaccine that could be used in countries with limited vaccine access"}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 10:35:10", "close_timestamp": 1637404510707, "created": "20/11/2021 10:35:11", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "2ecb84a7-e6bc-4a8a-840f-f72fe224ca1a", "open_date_time": "2021-10-20 10:29:38", "open_timestamp": 1637404178125, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "This story is about how GPs in Australia should start providing ivermectin trip therapy as a covid treatment instead of waiting for a vaccine because ivermectin has been proven to cure Covid", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 332582, "what": "how gps in australia should starting using ivermectin triple therapy to treat covid", "when_happened": "few_years_ago", "where_location": "australia", "who": "thomas borody, kylie wagstaff", "why": "says that ivermectin will be an effective covid cure if gps start prescribing it in australia"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 10:23:29", "close_timestamp": 1637403809658, "created": "20/11/2021 10:23:30", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "aff05186-20e3-4e22-9531-7da4b8bbdf07", "open_date_time": "2021-10-20 10:16:13", "open_timestamp": 1637403373226, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "An antibody treatment has been approved in Japan for patient use that reduces the risk of hospitalization from emerging variants, incuding the Delta varient. ", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 436432, "what": "government approved medications in japan", "when_happened": "today", "where_location": "japan", "who": "patients, governmenet, pharma, dr. osamu okuda", "why": "research on new medication, reduced hospitilization"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 11:4:18", "close_timestamp": 1637406258040, "created": "20/11/2021 11:04:19", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "af383ff3-2508-4cc4-98fd-557d7f37e113", "open_date_time": "2021-10-20 10:53:29", "open_timestamp": 1637405609016, "summary": "The Pfizer vaccine was proven to be effective in preventing Covid, which resulted in large profits for the company BioNTech. It continues to remain an effective treatment for Covid and has been proven to be effective against the \"Indian strain\" and a Brazilian variant and has been approved for use in adolesents by the FDA. The shelf-life has also been extended. Ultimately, the Pfizer vaccine has been very effective and provides a positive way out of the pandemic. It is very effective for both adolescents and children.", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 649024}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_11", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-20 10:53:10", "close_timestamp": 1637405590040, "created": "20/11/2021 10:53:10", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-20", "gender": "female", "id": "4be98dd0-3daf-4d51-996f-dc8206468c84", "open_date_time": "2021-10-20 10:41:36", "open_timestamp": 1637404896649, "summary": "The Astrazeneca vaccine, which was proven to be effective, is being used in more countries. The United States is donating extra vaccines. The phase III trials of Astrazeneca prove its effectiveness. This vaccine is effective against the \"Indian variant\". Astrazeneca reports high profits from this vaccine. There are some concerns of blood clots from this vaccine but they seem to be rare. There is some legal action happening between EU, UK, at Astrazeneca relating to so-called \"vaccine nationalism\" as Astrazeneca has not provided the proper amount of doses to the EU. ", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 693391}}}